发明名称 Arylethynyl pyrimidines
摘要 The present invention relates to ethynyl derivatives of formula I; wherein R1 is hydrogen or halogen;R2 is C1-3-alkyl or —(CH2)n—O—CH3;n is 2 or 3;m is 1 or 2; or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. ;It has been found that the compounds of general formula I are allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5) with improved properties for the treatment of schizophrenia, cognitive diseases, fragile X syndrome or autism.
申请公布号 US9199971(B2) 申请公布日期 2015.12.01
申请号 US201514622232 申请日期 2015.02.13
申请人 Hoffman-La Roche Inc. 发明人 Jaeschke Georg;Lindemann Lothar;Stadler Heinz;Vieira Eric
分类号 C07D403/04;A61K31/506 主分类号 C07D403/04
代理机构 代理人 Kale Tamara
主权项 1. An ethynyl derivative of formula I wherein R1 is hydrogen or halogen; R2 is C1-3-alkyl or —(CH2)n—O—CH3; n is 2 or 3; m is 1 or 2; or a pharmaceutically acceptable acid addition salt and/or optical isomer and/or stereoisomer thereof.
地址 Little Falls NJ US